Lepre Christopher A
Structural Biology, Vertex Pharmaceuticals, Incorporated, Cambridge, Massachusetts, USA.
Methods Enzymol. 2011;493:219-39. doi: 10.1016/B978-0-12-381274-2.00009-1.
NMR spectroscopy is a popular and highly versatile screening method for fragment-based drug discovery. NMR methods are capable of robustly detecting the binding of fragments to macromolecular targets over an extraordinarily broad affinity range (from covalent to millimolar). This chapter provides a stepwise process for creating an NMR-based fragment screening program. The construction of fragment libraries is described, including compound selection, plating of stocks, and preparation of mixtures. Guidance is given for designing fragment screens, such as choosing the appropriate NMR screening format and method, and optimizing the sample conditions and experimental parameters. The identification and validation of screening hits is described, and a number of potential pitfalls are discussed. Rather than detailing one specific screening protocol, this chapter outlines the available options and provides information to enable users to design their own customized fragment screening programs.
核磁共振光谱法是一种用于基于片段的药物发现的常用且用途广泛的筛选方法。核磁共振方法能够在非常宽的亲和力范围内(从共价结合到毫摩尔级)可靠地检测片段与大分子靶点的结合。本章提供了创建基于核磁共振的片段筛选程序的逐步流程。描述了片段库的构建,包括化合物选择、储备液铺板和混合物制备。给出了设计片段筛选的指导,例如选择合适的核磁共振筛选形式和方法,以及优化样品条件和实验参数。描述了筛选命中物的鉴定和验证,并讨论了一些潜在的陷阱。本章不是详细介绍一种特定的筛选方案,而是概述了可用的选项,并提供信息以使用户能够设计自己定制的片段筛选程序。